Our objectives ... include achieving the financial stability of the Egyptian healthcare system, maximizing the country’s medical resources, increasing the efficiency of the inventory management process,…
In Conversation
EIPICO will become the first company in the MENA region to produce biological products starting from the cell line all the way through upstream, downstream, formulation…
We are the shining star in the Middle East, with a strategic location, fantastic connectivity, effective governance and regulations – we expect these qualities to attract…
The positive side of COVID is that it helped accelerate the transformation of healthcare systems into ones with greater agility
[We] are trying to build a global/local mix of expertise to encourage greater numbers of trials to be placed in Saudi Arabia moving forward, which is…
Tarek El Rahbani – Senior Regional Director, EMEA Growth Emerging Markets – South, Boston Scientific
Our region is still developing, whereby the more we invest, the more training and education we do, the better access we create for patients and the…
The community DSP is building comprises global companies as well as startups and we offer opportunities to companies regardless of where they are in the value…
In 2021, almost 10 million people in the GCC were protected by Sanofi vaccines, a source of great pride which drives us forward
The Saudi government has invested heavily in healthcare and we, as an industry, consider it to be a strategic market in which most of Mecomed's companies…
The future is rosy. [Saudi Arabia] has good capabilities, the economy is growing, and the people are young, energetic, and well educated
Biopharmaceutical companies have a big role to play in advancing innovation for health and driving collaborations to deliver better healthcare outcomes.
The fact that Novo Nordisk in Saudi Arabia has been ranked as the No.1 ‘Best Places to Work’ for the last three years and ranked No.1…
